Impact of female gender on frequency of contrast medium-induced nephropathy: Post hoc analysis of dialysis versus diuresis trial

Journal of Women's Health

Volumn 19, Issue 7, 2010, Pages 1363-1368

  Kiski, Daniela ^a   Stepper, Wibke ^a   Breithardt, Günter ^a   Reinecke, Holger ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CONTRAST MEDIUM; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSIS; DIURESIS; FEMALE; HUMAN; HYDRATION; INTERMETHOD COMPARISON; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; POST HOC ANALYSIS; PRIORITY JOURNAL; WOMEN'S HEALTH;

ACUTE KIDNEY INJURY; AGED; ANALYSIS OF VARIANCE; CONFOUNDING FACTORS (EPIDEMIOLOGY); CONTRAST MEDIA; CREATININE; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 77954304103     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2009.1821     Document Type: Article

References (32)

1. Morcos SK, Thomsen HS. European Society of Urogenital Radiology. European Society of Urogenital Radiology guidelines on administering contrast media. Abdom Imaging 2003;28:187-190.
2. Nash K, Hafeez A, Hou S. Hospital-aquired renal insufficiency. Am J Kidney Dis 2002;39:930-936.
3. Barrett BJ, Parfrey PS. Clinical practice. Preventing ne-phropathy induced by contrast medium. N Engl J Med 2006;354:379-386.
4. Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000; 36:1542-1548.
5. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105:2259-2264.
6. Solomon R, Werner C, Mann D, et al. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994;331:1416-1420.
7. Tepel M, van der GM, Schwarzfeld C, et al. Prevention of radiographic-contrast agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000;343:180-184.
8. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996;275: 1489-1494.
9. Lindsay J, Canos DA, Apple S, et al. Causes of acute renal dysfunction after percutaneous coronary intervention and comparison of late mortality rates with postprocedure rise of creatine kinase-MB versus rise of serum creatinine. Am J Cardiol 2004;94:786-789.
10. McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368-375.
11. Reinecke H, Fobker M, Wellmann J, et al. A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy. Clin Res Cardiol 2007; 96:130-139.
12. Tadros G, Mouhayar E, Akinwande A, et al. Prevention of radiocontrast-induced nephropathy with N-acetylcysteine in patients undergoing coronary angiography. J Invas Cardiol 2003;15:311-314.
13. Baker C, Wragg A, Kumar S, et al. A rapid protocol for the prevention of contrast-induced renal dysfunction: The RAPPID study. J Am Coll Cardiol 2003;41:2114-2118.
14. Kay J, Chow W, Chan T, et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention. JAMA 2003;89: 356-358.
15. Shyu K, Cheng J, Peiliang K. Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol 2002; 40:1383-1388.
16. Mehran R, Amyong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J Am Coll Cardiol 2004;44:1393-1399.
17. Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and non-ionic contrast media in 1196 patients: A randomized trial. The Iohexol Cooperative Study. Kidney Int 1995;47:254-261.
18. Chanard J, Jolly D, Doco JB, et al. Nephrotoxicity of conventional and low osmolality radiocontrast media. J Nephrol 1991;4:203-209.
19. Iakovou I, Dangas D, Mehran R, et al. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. J Invas Cardiol 2003;15:18-22.
20. Mueller C, Buerkle G, Perruchoud AP. Female sex and risk of contrast nephropathy after percutaneous coronary intervention. Can J Cardiol 2004;20:505-509.
21. Gill NK, Piccione EA, Vido DA, et al. Gender as a risk factor for contrast nephropathy: Effects of hydration and N-acetylcysteine. Clin Cardiol 2004;27:554-558.
22. Nikolsky E, Mehran R, Lasic Z, et al. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int 2005;6:706-713. (Pubitemid 40139864)
23. Dangas G, Iakovou I, Nikolsky E, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 2005;95:13-19.
24. Bartholomew BA, Harjai KJ, Dukkipati S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 2004;93:1515-1519.
25. Sabeti S, Schillinger M, Mlekusch W, et al. Reduction in renal function after renal arteriography and after renal artery angioplasty. Eur J Vasc Endovasc Surg 2002;24:156-160.
26. Toprak O, Cirit M, Bayata S, et al. Review of the radio-contrast nephropathy risk profiles and risk stratification. Anadolu Kardiyol Derg 2004;4:331-335.
27. Goldschmidt-Clermont PJ, Schulman S, Bray PF, et al. Refining the treatment of women with unstable angina: A randomized, double-blind, comparative safety and efficacy evaluation of integrillin vs. aspirin in the management of unstable angina. Clin Cardiol 1996;19:869-874.
28. Okuniewski R, Davis EA, Jarr B, et al. A comparison of the development of renal hypertension in male and female rats. Clin Sci 1998;95:445-451.
29. Eaker ED, Chesebro JH, Sacks FM, et al. Cardiovascular disease in woman. Circulation 1993;88:1999-2009.
30. Sidhu RB, Brown JR, Robb JF, et al. Interaction of gender and age on postcardiac catheterization contrast-induced acute kidney injury. Am J Cardiol 2008;102:1482-1486.
31. Mosca L, Banka CL, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 2007;115:1481-1501. (Pubitemid 46648385)
32. Roger VL, Jacobsen SJ, Pellikka PA, et al. Gender differences in use of stress testing and coronary heart disease mortality: A population-based study in Olmsted Country, Minnesota. J Am Coll Cardiol 1998;32:345-352.